Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

May 08, 2018; 90 (19) ArticleOpen Access

Prevalence of preclinical Alzheimer disease

Comparison of current classification systems

Silke Kern, Henrik Zetterberg, Jürgen Kern, Anna Zettergren, Margda Waern, Kina Höglund, Ulf Andreasson, Hanna Wetterberg, Anne Börjesson-Hanson, Kaj Blennow, Ingmar Skoog
First published April 13, 2018, DOI: https://doi.org/10.1212/WNL.0000000000005476
Silke Kern
From the Department of Neuropsychiatric Epidemiology Unit (S.K., J.K., A.Z., M.W., H.W., A.B.-H., I.S.) and Clinical Neurochemistry Laboratory (S.K., H.Z., K.H., U.A., K.B.,), Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Sweden; and UCL Institute of Neurology (H.Z.), Queen Square, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henrik Zetterberg
From the Department of Neuropsychiatric Epidemiology Unit (S.K., J.K., A.Z., M.W., H.W., A.B.-H., I.S.) and Clinical Neurochemistry Laboratory (S.K., H.Z., K.H., U.A., K.B.,), Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Sweden; and UCL Institute of Neurology (H.Z.), Queen Square, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jürgen Kern
From the Department of Neuropsychiatric Epidemiology Unit (S.K., J.K., A.Z., M.W., H.W., A.B.-H., I.S.) and Clinical Neurochemistry Laboratory (S.K., H.Z., K.H., U.A., K.B.,), Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Sweden; and UCL Institute of Neurology (H.Z.), Queen Square, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Zettergren
From the Department of Neuropsychiatric Epidemiology Unit (S.K., J.K., A.Z., M.W., H.W., A.B.-H., I.S.) and Clinical Neurochemistry Laboratory (S.K., H.Z., K.H., U.A., K.B.,), Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Sweden; and UCL Institute of Neurology (H.Z.), Queen Square, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margda Waern
From the Department of Neuropsychiatric Epidemiology Unit (S.K., J.K., A.Z., M.W., H.W., A.B.-H., I.S.) and Clinical Neurochemistry Laboratory (S.K., H.Z., K.H., U.A., K.B.,), Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Sweden; and UCL Institute of Neurology (H.Z.), Queen Square, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kina Höglund
From the Department of Neuropsychiatric Epidemiology Unit (S.K., J.K., A.Z., M.W., H.W., A.B.-H., I.S.) and Clinical Neurochemistry Laboratory (S.K., H.Z., K.H., U.A., K.B.,), Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Sweden; and UCL Institute of Neurology (H.Z.), Queen Square, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ulf Andreasson
From the Department of Neuropsychiatric Epidemiology Unit (S.K., J.K., A.Z., M.W., H.W., A.B.-H., I.S.) and Clinical Neurochemistry Laboratory (S.K., H.Z., K.H., U.A., K.B.,), Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Sweden; and UCL Institute of Neurology (H.Z.), Queen Square, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hanna Wetterberg
From the Department of Neuropsychiatric Epidemiology Unit (S.K., J.K., A.Z., M.W., H.W., A.B.-H., I.S.) and Clinical Neurochemistry Laboratory (S.K., H.Z., K.H., U.A., K.B.,), Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Sweden; and UCL Institute of Neurology (H.Z.), Queen Square, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne Börjesson-Hanson
From the Department of Neuropsychiatric Epidemiology Unit (S.K., J.K., A.Z., M.W., H.W., A.B.-H., I.S.) and Clinical Neurochemistry Laboratory (S.K., H.Z., K.H., U.A., K.B.,), Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Sweden; and UCL Institute of Neurology (H.Z.), Queen Square, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kaj Blennow
From the Department of Neuropsychiatric Epidemiology Unit (S.K., J.K., A.Z., M.W., H.W., A.B.-H., I.S.) and Clinical Neurochemistry Laboratory (S.K., H.Z., K.H., U.A., K.B.,), Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Sweden; and UCL Institute of Neurology (H.Z.), Queen Square, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ingmar Skoog
From the Department of Neuropsychiatric Epidemiology Unit (S.K., J.K., A.Z., M.W., H.W., A.B.-H., I.S.) and Clinical Neurochemistry Laboratory (S.K., H.Z., K.H., U.A., K.B.,), Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Sweden; and UCL Institute of Neurology (H.Z.), Queen Square, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Prevalence of preclinical Alzheimer disease
Comparison of current classification systems
Silke Kern, Henrik Zetterberg, Jürgen Kern, Anna Zettergren, Margda Waern, Kina Höglund, Ulf Andreasson, Hanna Wetterberg, Anne Börjesson-Hanson, Kaj Blennow, Ingmar Skoog
Neurology May 2018, 90 (19) e1682-e1691; DOI: 10.1212/WNL.0000000000005476

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
2212

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Article Figures & Data

Figures

  • Tables
  • Figure
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure Venn diagram

    Venn diagram of the ATN distribution of amyloid and tau pathology according to the A/T/N classification scheme in a representative population-based sample of 70-year-olds with a Clinical Dementia Rating score of 0. A+ refers to Aβ pathology (CSF Aβ42 levels ≤530 pg/mL), T+ to pathologic p-tau (CSF p-tau ≥ 80 pg/mL), and N+ to neurodegeneration biomarker (CSF total tau ≥350 pg/mL) in 259 cognitively normal elderly all 70 years of age. Aβ = β-amyloid; p-tau = phosphorylated tau.

Tables

  • Figures
  • Table 1
  • Table 2
  • Table 3
  • Table 4
  • Table 5

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Glossary
    • Methods
    • Results
    • Discussion
    • Author contributions
    • Study funding
    • Disclosure
    • Acknowledgment
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy

Dr. Jeffrey Allen and Dr. Nicholas Purcell

► Watch

Related Articles

  • No related articles found.

Topics Discussed

  • Alzheimer's disease
  • Cohort studies
  • Prevalence studies

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Research Article
    Impact of C-Reactive Protein on Cognition and Alzheimer Disease Biomarkers in Homozygous APOE ɛ4 Carriers
    Qiushan Tao, Ting Fang Alvin Ang, Samia C. Akhter-Khan et al.
    Neurology, July 15, 2021
  • Article
    Elevated cerebrospinal fluid total tau in former professional athletes with multiple concussions
    Foad Taghdiri, Namita Multani, Apameh Tarazi et al.
    Neurology, May 08, 2019
  • Article
    White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease
    Anja Soldan, Corinne Pettigrew, Yuxin Zhu et al.
    Neurology, December 30, 2019
  • Article
    Sex differences in CSF biomarkers vary by Alzheimer disease stage and APOE ε4 genotype
    Rosha Babapour Mofrad, Betty M. Tijms, Philip Scheltens et al.
    Neurology, August 11, 2020
Neurology: 100 (12)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise